Streptococcus pneumoniae

31,448 views 27 slides Mar 09, 2017
Slide 1
Slide 1 of 27
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27

About This Presentation

morphology
cultural character
pathogenisis
labdiagnosis
prophylaxis
treatment


Slide Content

STREPTOCOCCUS PNEUMONIAE DR. RAJESH KUMAR R S

INTRODUCTION Gram positive, lanceolate shaped diplococcus Pneumococci Normal inhabitants of the human upper respiratory tract Pneumonia and Otitis media in children Sinusitis, Bronchitis, Bacteremia , Meningitis

MORPHOLOGY Small, slightly elongated cocci One end broad or rounded and the other pointed Flame shamed or lanceolate Pairs with broad ends in apposition Capsulated Typical morphology may not occur in culture India ink preperation

CULTURAL CHARACTERISTICS Enriched media Aerobes and facultative anaerobes On Blood agar, colonies are small (0.5 – 1 mm), dome shaped and glistening with α haemolysis Colonies become flat with raised edges and central umbonation Concentric rings on surface when viewed from above Draughtsman or carrom coin appearance Large Mucoid clonies ( types 3 and 7)

CULTURAL CHARACTERISTICS ß haemolysis in anaerobic conditions due to oxygen labile Hemolysin O Glucose broth – uniform turbidity Autolysis Autolysis is enhanced by bile salts, Sodium lauryl sulphate and surface active agents Heat killed cultures do not undergo autolysis

BIOCHEMICAL REACTIONS Catalase and oxidase negative Hiss’s serum sugars Ferments Inulin Bile solubility test: If a few drops of 10% sodium deoxycholate are added to 1 mL of an overnight broth culture, the culture clears due to lysis of cocci . Autolytic amidase that cleaves the bond between alanine and muramic acid in the peptidoglycan Amidase is activated by bile salts

RESISTANCE 52° C for 15 minutes Cultures die on prolonged incubation due to accumulation of toxic peroxides Sensitive to beta lactam antibiotics Optochin (Ethyl hydrocuprein ) sensitive

ANTIGENIC PROPERTIES Capsule Nucleoprotein antigen ‘C’ carbohydrate antigen C – reactive protein (CRP) acute phase protein ( Beta globulin) bacterial infections, inflammation, malignancy and tissue destruction

CAPSULE Capsular polysaccharide Specific Soluble Substance (SSS) 90 serotypes named 1, 2, 3 and so on Serotyping carried out by agglutination, Precipitation or Quellung reaction Nuefeld (1902) Suspension of S. pneumoniae is mixed on a slide with a drop of type specific antiserum and a loopful of methylene blue Capsule becomes swollen and refractile

VARIATION Smooth to rough (S – R) variation In the R form, cocci are non capsulated, autoagglutinable and avirulent Spontaneous mutants In tissues R mutants are eliminated by phagocytosis Rough S. pneumoniae of one serotype may be made to produce capsules of the same or different serotype, on treatment with DNA from the respective serotypes Transformation by Griffith

TOXINS AND VIRULENCE FACTORS Capsular Polysaccharide Protects the cocci from phagocytosis Surface phagocytosis Enhanced virulence of type 3 Non capsulated strains are avirulent Antibody to capsular polysaccharide is protective Pneumolysin Autolysin Oxygen labile hemolysin and leucocidin

PATHOGENICITY Fatal infection in mice & rabbits Colonise the human Nasopharynx Infection of middle ear, Paranasal sinuses and Respiratory tract Meningitis Bacteremia may lead to infection in the heart, peritoneum or joints Endgoenous infection Exogenous infection

PATHOGENICITY Lobar and Bronchopneumonia Acute tracheobronchitis and Empyema Aspiration of nasopharyngeal secretions Bacteremia Bronchopneumonia is always a secondary infection in aged and debilitated patients Acute exacerbations in Chronic Bronchitis

Meningitis Secondary to Pneumonia, Otitis media, Sinusitis or conjunctivitis Occur at all ages Highly fatal 25% fatality even with antibiotic therapy

SUPPURATIVE LESIONS Empyema Pericarditis Otitis media Sinusitis Conjunctivitis Suppurative arthritis Peritonitis Keratitis and Dacryocystitis

EPIDEMIOLOGY S. pneumoniae occurs in the throats of 50% of human population Droplets Dissemination is facilitated by crowding Infection usually leads to pharyngeal carriage Disease results when host resistance is lowered by viral infection, stress, malnutrition, immunodeficiency or alcoholism Splenectomy and Sickle cell disease

Serotypes vary greatly in virulence Type 3 is the most virulent Common infections – Otitis media, Sinusitis Serotypes 6, 14, 19F and 23F are commonly seen in West In adults, type 1 – 8 are responsible for about 75% of Pneumonia In children type 6, 14, 19 and 23 are frequent causes Lobar pneumonia is sporadic Bronchopneumonia increases with an epidemic of Influenza Common in winter and affect the two extreme age groups

LABORATORY DIAGNOSIS Specimen – Sputum, CSF, Blood and Urine Microscopy – Gram stain of rusty sputum Culture – Blood agar (5 – 10% CO 2 ) Gentamicin (5 µg/Ml) Blood culture in Glucose broth Mouse inoculation (negative in type 14 strain)

ANTIGEN DETECTION SSS in CSF can be detected by Precipitation or Latex agglutination test Capsular polysaccharide can be demonstrated by counterimmunoelectrophoresis Immunochromatography CRP Procalcitonin PCR

PROPHYLAXIS Immunity is type specific 7- valent conjugate vaccine CRM 197 protein of Corynebacterium diptheriae Children from 2 months to 2 years Polyvalent polysaccharide vaccine

POLYVALENT POLYSACCHARIDE VACCINE Capsular antigens of the 23 most prevalent serotypes 80 – 90 % protection Not meant for general use Absent or Dysfunctional spleen Sickle cell disease Chronic heart, renal, lung and celiac disease Diabetes mellitus HIV

TREATMENT Parental Penicillin Amoxycillin Alteration in Penicillin Binding Protein Third generation cephalosporins vancomycin

THANK U
Tags